US 11,667,656 B2
Crystalline forms of Tenofovir alafenamide
Fabio E. S. Souza, Brantford (CA); Avedis Karadeolian, Brantford (CA); and Alexander J. Stirk, Brantford (CA)
Assigned to Apotex Inc., Toronto (CA)
Filed by Apotex Inc., Toronto (CA)
Filed on Jan. 27, 2021, as Appl. No. 17/159,238.
Prior Publication US 2022/0235079 A1, Jul. 28, 2022
Int. Cl. C07F 9/6561 (2006.01); A61K 45/06 (2006.01)
CPC C07F 9/65616 (2013.01) [A61K 45/06 (2013.01); C07B 2200/13 (2013.01)] 20 Claims
 
1. A crystalline form of tenofovir alafenamide succinate fumarate comprising tenofovir alafenamide, succinic acid, and fumaric acid.